Mycofoli 540 Tablet contains Mycophenolate Sodium 540 mg, a potent immunosuppressant widely used in organ transplant medicine to prevent graft rejection.
This tablet works by inhibiting inosine monophosphate dehydrogenase (IMPDH), suppressing T- and B-lymphocyte proliferation and reducing immune-mediated damage to transplanted organs. It is ideal for patients requiring mid- to high-dose immunosuppression under strict medical supervision.
Clinically, Mycofoli 540 Tablet is prescribed in renal, hepatic, and cardiac transplant regimens, often as part of combination immunosuppressive therapy to ensure graft stability and long-term transplant success.
The tablet ensures accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it suitable for hospitals, transplant centers, specialty clinics, and pharmacies managing advanced post-transplant immunosuppressive therapy.